CompletedPhase 2NCT01802489
Amiloride Clinical Trial In Optic Neuritis
Studying Isolated optic neuritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Oxford
- Principal Investigator
- Matthew Craner, MBChB PhDUniversity of Oxford
- Intervention
- Amiloride(drug)
- Enrollment
- 46 target
- Eligibility
- 18-55 years · All sexes
- Timeline
- 2013 – 2015
Study locations (1)
- John Radcliffe Hospital, Oxford, United Kingdom
Collaborators
Multiple Sclerosis Society of Great Britain and Northern Ireland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01802489 on ClinicalTrials.govOther trials for Isolated optic neuritis
Additional recruiting or active studies for the same condition.